Innovation Mechanism 2: Collective Creativity

Want to bring out the best ideas from your organization? Follow my blog series on the innovation mechanisms that enable new ideas to become great products.

Successful innovators seek to learn – not to convince.

A group of creative individuals can generate collective creativity.  Innovation is the process of newly applying ideas to problems, generating novel solutions.  When people interact, they gain access to each other’s experience, and activate associations across far-flung bodies of knowledge.

Recommendations: Build a culture of learning, not telling

Unlearn the habits of academia.

Admitting you don’t know is a sign of integrity, not a source of shame.

A presentation is not a dissertation defense.

When presenting, your job is enabling others to learn, not defending.

When watching, your job is learning, not grading.

Proving which idea belongs to whom interferes with problem-solving.

Questioning someone senior is a knowledge-building move, not a career-limiting move.

Reduce dependence on PowerPoint.

Writing PowerPoint slides suppresses the cognitive activity of synthesizing knowledge because it encourages people to divide information into discrete, sequential pieces organized in rigid outlines.

Innovation, in contrast, connects information in associative networks.  Full sentences in prose paragraphs better express the integration of different strands of thought that result in new solutions.

Model high-quality conversation at the top.

Train and coach senior executives on the disciplines of collaborative leadership:

Skillful reflection on the different perspectives underlying technical and business decisions.

Building solid understanding of the critical data and reasoning for taking action.

Bringing out the whole range of concerns and ideas that bear on the issues at hand.

 

Click here for a free download of the Kummer Consulting White Paper, Designing a New Engine for Life Science Innovation.

For a free consultation on how to improve your organization’s effectiveness contact Merle at mkummer@kummerconsulting.com

Follow my New Blog, Merle Kummer Insights

I’m delighted to begin sharing the insights that emerge from the deeply satisfying work of helping biopharma leaders innovate.  Every day, I have the privilege of reflecting on problems at the edge of innovation with committed scientists and leaders.  Every time we succeed with a new approach, I think of a dozen people who could use the ideas, and wish I could call every one of you. That being impossible, I’ll post what we learn and hope to inspire you.  If you try something out, call me at 617-489-9964 any time!

I’ll begin 2018 with a 6-part biweekly series on the mechanisms of innovation that drive sustainable performance for R&D organizations.   These are drawn from the White Paper Designing a New Engine for Life Science Innovation, a practical case study showing the mechanisms at work.

Innovation Mechanism 1: Individual Scientific Creativity

Daunted by the challenge of keeping your organization innovative? Follow my new series on mechanisms that drive sustainable performance.

Creativity fuels the innovation organization.

Research on creativity shows that long incubation, broad investigation, and wide experience enable scientists to synthesize knowledge from disparate sources to create new ideas.

Recommendation: Find creative individuals

Value broad thinking, not just subject-matter expertise.

Biopharma organizations typically look for employees, advisors, and collaborators with experience in precise technical and scientific domains. This can filter out people who can assemble novel solutions from a variety of sources.

Look far beyond your own network.

People that you already know tend to know what you already know. Don’t let your own experience limit your ability to access domains of knowledge that can increase the value of your ideas.

Seek people with deep interests outside their professional domains.

Passionate engagement in a pursuit beyond one’s specialty is a strong clue to a creative mind.

Require curiosity.

Anyone who doesn’t ask questions won’t learn enough to provide better answers.

Click here for a free download of the Kummer Consulting White Paper, Designing a New Engine for Life Science Innovation.

For a free consultation on how to improve your organization’s effectiveness contact Merle at mkummer@kummerconsulting.com

Finding the Best Path to a Clinical Protocol Design

Can’t get people out of their silos?

You’re not alone.

Problem: An early-stage company needed to demonstrate Proof of Concept for a novel therapy, but the organization could not reach agreement on a clinical protocol design.

My client Peter, the Program Executive, vented his frustration to me:

“Dr. C [the Clinical Director] withdraws, withholds information, doesn’t inform me or the program team about anything, comes up with a suboptimal design, gets his boss on board, the Portfolio Review Committee rejects the proposal, and we end up losing a lot of time. This has happened a couple of times already.”

The Portfolio Committee told the team that the only solution was to bring in outside experts.

Solution: Instead of blaming Clinical, I helped the Program Executive step back. Read more

Innovating In Highly Regulated Settings

Find it hard to innovate in the strictly regulated environment of drug development?

You’re not alone.

Problem: Recently, a client company faced a competitive threat to their leading product. The FDA issued new manufacturing guidelines that would have taken three years to implement, while their competition had already complied. The PD (process development) team proposed an innovative method that would cut two years out of implementation and save $10 million. The problem was that their executive team said it was too risky to recommend to the FDA.

Read more